Vitamin E alleviates non-alcoholic fatty liver disease in phosphatidylethanolamine N-methyltransferase deficient mice.
Acid Ceramidase
Animals
Antioxidants
/ pharmacology
Cholesterol
/ metabolism
Diet, High-Fat
Dietary Supplements
Disease Models, Animal
Disease Progression
Fatty Liver
/ metabolism
Fibrosis
/ drug therapy
Inflammation
/ drug therapy
Insulin Resistance
Lipid Metabolism
Liver
/ drug effects
Male
Mice
Mice, Inbred C57BL
Mice, Knockout
Non-alcoholic Fatty Liver Disease
/ metabolism
Obesity
/ metabolism
Oxidative Stress
/ drug effects
Phosphatidylethanolamine N-Methyltransferase
/ genetics
Phosphotransferases (Alcohol Group Acceptor)
RNA, Messenger
Vitamin E
/ administration & dosage
Antioxidant
Ceramide
Non-alcoholic fatty liver disease
Oxidative stress
Phosphatidylcholine
Vitamin E
Journal
Biochimica et biophysica acta. Molecular basis of disease
ISSN: 1879-260X
Titre abrégé: Biochim Biophys Acta Mol Basis Dis
Pays: Netherlands
ID NLM: 101731730
Informations de publication
Date de publication:
01 2019
01 2019
Historique:
received:
29
05
2018
revised:
27
09
2018
accepted:
05
10
2018
pubmed:
10
10
2018
medline:
14
8
2019
entrez:
10
10
2018
Statut:
ppublish
Résumé
Phosphatidylethanolamine N-methyltransferase (PEMT) converts phosphatidylethanolamine (PE) to phosphatidylcholine (PC), mainly in the liver. Pemt
Identifiants
pubmed: 30300671
pii: S0925-4439(18)30387-9
doi: 10.1016/j.bbadis.2018.10.010
pii:
doi:
Substances chimiques
Antioxidants
0
RNA, Messenger
0
Vitamin E
1406-18-4
Cholesterol
97C5T2UQ7J
PEMT protein, mouse
EC 2.1.1.17
Phosphatidylethanolamine N-Methyltransferase
EC 2.1.1.17
Phosphotransferases (Alcohol Group Acceptor)
EC 2.7.1.-
ceramide kinase
EC 2.7.1.138
Acid Ceramidase
EC 3.5.1.23
Asah1 protein, mouse
EC 3.5.1.23
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Pagination
14-25Subventions
Organisme : CIHR
ID : MOP 5182
Pays : Canada
Informations de copyright
Copyright © 2018 Elsevier B.V. All rights reserved.